| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus cohnii |
>0.12 |
>8 |
≤0.06 － >8 |
Clindamycin (Cleocin)  |
472 |
| Staphylococcus cohnii |
0.25 |
0.5 |
0.03 － 1 |
Tigecycline (GAR-936, Tigacyl) |
472 |
| Staphylococcus cohnii |
0.25 |
0.5 |
0.06 － 2 |
Daptomycin (Cubicin) |
472 |
| Staphylococcus cohnii |
0.25 |
0.5 |
≤0.25 － >8 |
Quinupristin/Dalfopristin (Synercid) |
472 |
| Staphylococcus cohnii |
1 |
1 |
0.12 － 2 |
Linezolid (PNU-100766, U-100766, Zyvox) |
472 |
| Staphylococcus cohnii |
1 |
2 |
0.25 － 4 |
Vancomycin (Vancocyn, Lyphocin) |
472 |
| Staphylococcus cohnii |
>1 |
>2 |
≤0.5 － >2 |
Co-trimoxazole (Trimethoprim-sulfamethoxazole, TMP-SMX) |
472 |
| Staphylococcus cohnii |
>2 |
>2 |
≤0.06 － >2 |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
472 |
| Staphylococcus cohnii |
>2 |
>4 |
≤0.03 － >4 |
Levofloxacin (Levaquin, Quixin) |
472 |
| Staphylococcus cohnii |
>2 |
>8 |
≤2 － >8 |
Tetracycline (Sumycin, Achromycin V, Steclin) |
472 |
| Staphylococcus cohnii |
2 |
8 |
≤2 － >16 |
Teicoplanin (Targocid) |
472 |
| Staphylococcus cohnii |
2 |
- |
0.25 － 2 |
Cefprozil (Cefzil) |
1492 |
| Staphylococcus cohnii |
2 |
- |
0.5 － 4 |
Cefuroxime (Kefurox, Zinacef) |
1492 |
| Staphylococcus cohnii |
4 |
- |
0.25 － 8 |
Cefaclor (Ceclor, Ceclor CD) |
1492 |
| Staphylococcus cohnii |
8 |
- |
2 － 8 |
Cefpodoxime |
1492 |
| Staphylococcus cohnii |
64 |
- |
8 － >64 |
Cefixime (Suprax) |
1492 |
| Staphylococcus cohnii |
>64 |
- |
>64 － ? |
Ceftibuten (Cedax) |
1492 |
| Staphylococcus cohnii |
- |
- |
7.81 － ? |
Cefepime (Maxipime) |
348 |
| Staphylococcus cohnii |
- |
- |
250 － ? |
Ziziphora persica (Essential oil) |
348 |
| Staphylococcus cohnii |
- |
- |
250 － ? |
Ziziphora persica (Methanol extract) |
348 |
| Staphylococcus cohnii (212) |
- |
- |
0.25 － ? |
Ampicillin (Omnipen) |
220 |
| Staphylococcus cohnii (212) |
- |
- |
0.25 － ? |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
220 |
| Staphylococcus cohnii (coagulase-negative + oxacillin-susceptible) |
0.12 |
0.25 |
≤0.06 － >8 |
Clindamycin (Cleocin) |
412 |
| Staphylococcus cohnii (coagulase-negative + oxacillin-susceptible) |
0.12 |
2 |
≤0.03 － >4 |
Gatifloxacin (Tequin) |
412 |
| Staphylococcus cohnii (coagulase-negative + oxacillin-susceptible) |
>0.25 |
>2 |
0.06 － >2 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
412 |
| Staphylococcus cohnii (coagulase-negative + oxacillin-susceptible) |
≤0.5 |
≤0.5 |
≤0.5 － >8 |
Imipenem |
412 |
| Staphylococcus cohnii (coagulase-negative + oxacillin-susceptible) |
0.5 |
1 |
≤0.5 － 8 |
Zosyn |
412 |
| Staphylococcus cohnii (coagulase-negative + oxacillin-susceptible) |
0.5 |
2 |
≤0.12 － 8 |
Cefepime (Maxipime) |
412 |